Ying Xiao

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

Type 1, Firefish Part 2, Rehabilitation +6

Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta

Zhong-Yan Zhou, Wai-Rong Zhao, Wenting Shi et al. · Frontiers in Pharmacology · 2019 · 49 citations · Full text

MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2)

Rihan Wu, Qinyu He, Haitao Chen et al. · Biochemical and Biophysical Research Communications · 2017 · 43 citations

Signaling Pathway, Th17 Response, Immune Cell Development +10

Intracellular calcium current disorder and disease phenotype in <i>OBSCN</i> mutant iPSC-based cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy

Peipei Chen, Ying Xiao, Yuanpin Wang et al. · Theranostics · 2020 · 39 citations · Full text

SpyTag/SpyCatcher cyclization enhances the thermostability and organic solvent tolerance of l-phenylalanine aldolase

Yida Wang, Junwei Tian, Ying Xiao et al. · Biotechnology Letters · 2019 · 34 citations

Organic Solvent Tolerance, Biosynthesis, Bioorganic Chemistry +11